Home Equities Score Cerevel Therapeutics Inc. (CERE) stock plunged during after-hours, post massive gains.

Cerevel Therapeutics Inc. (CERE) stock plunged during after-hours, post massive gains.

Cerevel Therapeutics Inc. (NASDAQ: CERE) stock gained by 136.2% at last close whereas the CERE stock price has been observed declining by 6.26% during after-hours session. Cerevel Therapeutics is devoted to solving the brain’s secrets in order to cure neurological disorders. CERE is treating illnesses with a focused neuroscience strategy that blends neurocircuitry expertise with a focus on receptor selectivity.

>> 7 Top Picks for the Post-Pandemic Economy << 

What is happening?

Cerevel Therapeutics has published encouraging findings on June 29, 2021 from its Phase 1b clinical trial in adult patients with schizophrenia using CVL-231 which is a new muscarinic M4-selective Positive Allosteric Modulator (PAM). CVL-231 was safe and well accepted, with dropout rates of 22 percent for both CVL-231 and placebo after six weeks of treatment. Importantly, as opposed to placebo, both the 30 mg once-daily and 20 mg twice-daily dosages showed clinically significant antipsychotic efficacy with an overall well-tolerated profile.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

The CVL-231 30 mg once-daily dose appears to result substantial and clinically important mean reduction in the Positive and Negative Syndrome Scale (PANSS) total score of 19.5 points from baseline, as well as a mean reduction of 12.7 points in PANSS compared to the placebo group (p=0.023). When compared to the placebo group, the CVL-231 20 mg twice-daily dosage resulted in a statistically significant and clinically relevant mean reduction in PANSS total score of 17.9 points from baseline and a mean reduction of 11.1 points in PANSS total score (p=0.047). Clinically significant decreases in the PANSS Positive and PANSS Negative subscales backed up these findings.

Furthermore,

On the same day, Cerevel Therapeutics has also announced the start of a 14,000,000 share underwritten public offering of its common stock. Cerevel plans to give the underwriters a 30-day opportunity to buy up to an additional 2,100,000 shares of common stock at the public offering price, less underwriting discounts and fees, in conjunction with this offering. The offering is dependent on the market and other factors, and no guarantee can be given as to whether or when it will be finalized, or as to the size or terms of the offering. Cerevel will sell all of the shares in the proposed sale.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

SPX Flow Inc. (FLOW) stock surged during current market. Here’s why the stock is sky-rocketing?

SPX Flow Inc. (NASDAQ: FLOW) stock gained by 24.24% in the current market trading session. SPX FLOW, based in Charlotte, works to make the...

Platinum Group Metal Ltd. (PLG) stock surges during after-market trading. Here’s to know what’s happening?

Platinum Group Metal Ltd. (NASDAQ: PLG) stock declined by 8.54% at last close whereas the PLG stock price gains by 7% in the after-market...

TD Holdings Inc. (GLG) stock gains during current market trading. Here’s the recent update

TD Holdings Inc. (NASDAQ: GLG) stock gains by 5.01% in the current market trading session. TD Holdings, Inc. is a service provider in China...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

NeuroMetrix Inc. (NURO) stock plunged during pre-market. Let’s find out why?

NeuroMetrix Inc. (NASDAQ: NURO) stock gained by 18.89% at last close while the NURO stock price losses by -4.12% in the pre-market trading session....

Related News

TD Holdings Inc. (GLG) stock gains during current market trading. Here’s the recent update

TD Holdings Inc. (NASDAQ: GLG) stock gains by 5.01% in the current market trading session. TD Holdings, Inc. is a service provider in China...

NeuroMetrix Inc. (NURO) stock plunged during pre-market. Let’s find out why?

NeuroMetrix Inc. (NASDAQ: NURO) stock gained by 18.89% at last close while the NURO stock price losses by -4.12% in the pre-market trading session....

DMC Global Inc. (BOOM) stock declines during pre-market trading. Here’s what you should know

DMC Global Inc. (NASDAQ: BOOM) stock plunged by 6.50% at last close while the BOOM stock price fell further by 13.06% in the pre-market...

Boston Beer Company Inc. (SAM) stock fell during after-hour trading. Here’s the recent update

Boston Beer Company Inc. (NASDAQ: SAM) stock gains by 1.89% at last close whereas the SAM stock price plunged by 18.64% in the after-hours...

Jupiter Wellness, Inc. (JUPW) Stock Plummets Following Pricing of Underwritten Public Offering

Jupiter Wellness, Inc. (JUPW) stock prices were down 15.45% as of the market closing on July 21st, 2021, bringing the price per share down...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam